Splenectomized versus non-splenectomized patients with thalassemia major: Echocardiographic comparison

Saudi Medical Journal

Volumn 29, Issue 9, 2008, Pages 1310-1314

  Morsy, Mohamed Mofeed F ^a,b   Abnajjar, Abdulhameed A ^b   Almuzainy, Ibrahim S ^b   Alhawsawi, Zakria M ^b   Alserafi, Mona H ^c   Ahmed, Ali A ^a  

^a Sohag University   (Egypt)

^b King Salman Bin Abdulaziz Medical City   (Saudi Arabia)

^c Madina Meternity and Children's Hospital   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; IRON CHELATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PULMONARY HYPERTENSION; RISK ASSESSMENT; SAUDI ARABIA; SPLENECTOMY; THALASSEMIA MAJOR; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; PROSPECTIVE STUDIES; SPLENECTOMY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 58049114864     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Rund D, Rachmilewitz E. New trends in the treatment of beta-thalassemia. Crit Rev Oncol Hematol 2000; 33: 105-118.
2. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassemia major. Lancet 1989; 2: 27-30.
3. Al-Salem AH, Nasserulla Z. Splenectomy for children with thalassemia. Int Surg 2002; 87: 269-273.
4. Graziano JH, Piomelli S, Hilgartner M, Giardina P, Karpatkin M, Andrews M, et al. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance. J Pediatr 1981; 99: 695-699.
5. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
6. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA, Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-184.
7. Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 1985; 6: 359-365.
8. Kircher BJ, Himelman RB, Shiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 66: 493-496.
9. Otto CM. Echocardiographic evaluation of left and right ventricular systolic function. In: Otto CM, editor. Textbook of clinical echocardiography. 2nd ed. Philadelphia (PA): WB Saunders; 2000. p. 100-128.
10. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70: 657-662.
11. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: S40-S47.
12. Al-Hawsawi ZM, Hummaida TI, Ismail GA. Splenectomy in thalassemia major: experience at Madina Maternity and Children's Hospital, Saudi Arabia. Ann Trop Paediatr 2001; 21: 155-158.
13. Al-Hawsawi ZM, Hummaida TI. Splenic abscess in childhood B-Thalassemia Major. Saudi Med J 2002 23: 345-347.
14. Phrommintikul A, Sukonthasarn A, Kanjanavanit R, Nawarawong W. Splenectomy: A strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart 2006; 92: 1467-1472.
15. Piomelli S. The splenectomy controversy. Ann N Y Acad Sci 2005; 1054: 511-513.
16. Davis BA, O'Sullivan C, Jarritt PH, Porter JB. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood 2004; 104: 263-269.
17. Aessopos A, Farmakis D, Tsironi M, Deftereos S, Tassiopoulos S, Konstantopoulos K, et al. Hemodynamic assessment of splenomegaly in beta-thalassemia patients undergoing splenectomy. Ann Hematol 2004; 83: 775-778.
18. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Polonifi A, Moyssakis I, et al. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia. Ann Hematol 205; 84: 353-357.
19. Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J 1997; 134: 532-537.
20. Grisaru D, Rachmilewitz EA, Mosseri M, Gotsman M, Lafair JS, Okon E, et al. Cardiopulmonary assessment in beta-thalassemia major. Chest 1990; 98: 1138-1142.
21. Derchi G, Fonti A, Forni GL, Galliera EO, Cappellini MD, Turati F, et al. Pulmonary hypertension in patients with thalassemia major. Am Heart J 1999; 138: 384.
22. Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, et al. Cardiac involvement in thalassemia intermedia: A multicenter study. Blood 2001; 97: 3411-3416.
23. Factor JM, Pottipati SR, Rappoport I, Rosner IK, Lesser ML, Giardina PJ. Pulmonary function abnormalities in thalassemia major and the role of iron overload. Am J Respir Crit Care Med 1994; 149: 1570-1574.
24. Zakynthinos E, Vassilakopoulos T, Kaltsas P, Malagari E, Daniil Z, Roussos C, et al. Pulmonary hypertension, interstitial lung fibrosis, and lung iron deposition in thalassaemia major. Thorax 2001; 56: 737-739.
25. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-895.
26. Singer ST, Kuypers FA, Styles L, Vichinsky EP, Foote D, Rosenfeld H. Pulmonary hypertension in thalassemia: Association with platelet activation and hypercoagulable state. Am J Hematol 2006; 81: 670-675.
27. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99: 36-43.
28. Cappellini MD, Grespi E, Cassinerio E, Bignamini D, Fiorelli G. Coagulation and splenectomy: An overview. Ann N Y Acad Sci 2005; 1054: 317-324.
29. Al Hawsawi ZM, Haouimi AS, Hassan RA, Tarawah AM. Portal vein thrombosis after splenectomy for beta-thalassemia major. Saudi Med J 2004; 25: 225-228.
30. Stewart GW, Amess JA, Eber SW, Kingswood C, Lane PA, Smith BD, et al. Thrombo-embolic disease after splenectomy for heredity stomatocytosis. Br J Haematol 1996; 93: 303-310.
31. Chou R, DeLoughery TG. Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. Am J Hematol 2001; 67: 197-199.
32. Mistry PK, Sirrs S, Chan A, Pritzker MR, Duffy TP, Grace ME, et al. Pulmonary hypertension in type 1 Gaucher's disease: Genetic and epigenetic determinants of phenotype and response to therapy. Mol Genet Metab 2002; 77: 91-98.
33. Hoeper MM, Niedermeyer J, Hoffmeyer F, Flemming P, Fabel H. Pulmonary hypertension after splenectomy? Ann Intern Med 1999; 130: 506-509.